Thyrocare Technologies Rises After Reporting 80% Jump in Q2 Consolidated Net Profit

Mumbai, October 15 (Udaipur Kiran): Shares of Thyrocare Technologies gained after the diagnostic services major reported a sharp 79.94% rise in consolidated net profit for the second quarter ended September 30, 2025 (Q2FY26). The stock was trading at Rs. 1267.70, up by 3.10 points or 0.25% from its previous close of Rs. 1264.60 on the BSE.

Thyrocare Technologies

The scrip opened at Rs. 1470.00 and recorded a high of Rs. 1470.00 and a low of Rs. 1229.20 during the session. Around 5,24,905 shares were traded on the counter. The BSE Group ‘B’ stock, with a face value of Rs. 10, has touched a 52-week high of Rs. 1470.00 (15-Oct-2025) and a 52-week low of Rs. 658.00 (04-Mar-2025).

During the past week, the stock traded between Rs. 1470.00 and Rs. 1195.00. The company’s current market capitalisation stands at Rs. 6,662.46 crore. Promoters hold 71.06%, while institutional and non-institutional investors hold 18.32% and 10.63%, respectively.

For the quarter ended September 30, 2025, the company reported a 45.42% rise in standalone net profit to Rs. 43.03 crore, compared to Rs. 29.59 crore in the same period last year. Total income increased by 23.82% to Rs. 204.51 crore, as against Rs. 165.17 crore in the corresponding quarter of the previous year.

On a consolidated basis, Thyrocare’s net profit rose nearly 80% to Rs. 47.99 crore, compared to Rs. 26.67 crore a year ago. Total income grew 22.01% to Rs. 219.58 crore, up from Rs. 179.97 crore in Q2FY25.

The robust quarterly performance reflects strong growth in diagnostic volumes and sustained expansion in revenue from preventive and wellness testing segments, reinforcing Thyrocare’s position as one of India’s leading diagnostic networks.

BREAKING NEWS:
“Govinda’s niece trolled for bikini look, loses followers!” 150-inch screen for ₹7,999: Lifelong mini projector launched! Jio launches new 31-day recharge plan at ₹339!